# Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

> **NCT00567164** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 1887 (actual)

## Conditions studied

- Contraception
- Ovulation Inhibition
- Contraceptives, Oral

## Interventions

- **DRUG:** EE20/DRSP (BAY86-5300)
- **DRUG:** EE20/DRSP (BAY86-5300)
- **DRUG:** EE20/DRSP (YAZ, BAY86-5300)

## Key facts

- **NCT ID:** NCT00567164
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 1887 (ACTUAL)
- **Last updated:** 2014-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567164, "Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00567164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*